| 1 |
Puhach O, Bellon M, Adea K, Bekliz M, Hosszu-fellous K, Sattonnet P, Coudurier-boeuf S, Arm-vernez I, Kaiser L, Eckerle I, Meyer B. SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses.. [DOI: 10.1101/2023.03.24.23287677] [Reference Citation Analysis]
|
| 2 |
Poydenot F, Lebreton A, Haiech J, Andreotti B. At the crossroads of epidemiology and biology: Bridging the gap between SARS-CoV-2 viral strain properties and epidemic wave characteristics. Biochimie 2023:S0300-9084(23)00068-8. [PMID: 36931337 DOI: 10.1016/j.biochi.2023.03.006] [Reference Citation Analysis]
|
| 3 |
McCormick DW, Hagan LM, Salvatore PP, Magleby R, Lee C, Sleweon S, Nicolae L, Dixon T, Banta R, Ogle I, Young C, Dusseau C, Ogden C, Browne H, Michael Metz J, Chen MH, Solano MI, Rogers S, Burgin A, Sheth M, Bankamp B, Tamin A, Harcourt JL, Tate JE, Kirking HL; COVID-19 Surge Diagnostics Laboratory Teams. SARS-CoV-2 viral shedding in vaccinated and unvaccinated persons: A case series. Vaccine 2023;41:1769-73. [PMID: 36435706 DOI: 10.1016/j.vaccine.2022.11.030] [Reference Citation Analysis]
|
| 4 |
Port JR, Morris DH, Riopelle JC, Yinda CK, Avanzato VA, Holbrook MG, Bushmaker T, Schulz JE, Saturday TA, Barbian K, Russel CA, Perry-Gottschalk R, Shaia CI, Martens C, Lloyd-Smith JO, Fischer RJ, Munster VJ. Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster. bioRxiv 2023:2022. [PMID: 36032963 DOI: 10.1101/2022.08.15.504010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Teyssou E, Marot S, Cocherie T, Fauchois A, Abdi B, Todesco E, Akhavan S, Pourcher V, Calvez V, Marcelin AG, Soulie C. Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patients. Infect Dis Now 2023;53:104629. [PMID: 36323397 DOI: 10.1016/j.idnow.2022.10.001] [Reference Citation Analysis]
|
| 6 |
Stokes W, Venner AA, Buss E, Tipples G, Berenger BM. Evaluation of the ID NOW among symptomatic individuals during the Omicron wave. J Med Microbiol 2023;72. [PMID: 36848403 DOI: 10.1099/jmm.0.001669] [Reference Citation Analysis]
|
| 7 |
Armas F, Chandra F, Lee WL, Gu X, Chen H, Xiao A, Leifels M, Wuertz S, Alm EJ, Thompson J. Contextualizing Wastewater-Based surveillance in the COVID-19 vaccination era. Environ Int 2023;171:107718. [PMID: 36584425 DOI: 10.1016/j.envint.2022.107718] [Reference Citation Analysis]
|
| 8 |
Mueller S. Omicron. Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2 2023. [DOI: 10.1007/978-3-031-18903-6_12] [Reference Citation Analysis]
|
| 9 |
Meurisse M, Van Oyen H, Blot K, Catteau L, Serrien B, Klamer S, Cauët E, Robert A, Van Goethem N. Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data. BMC Infect Dis 2022;22:839. [DOI: 10.1186/s12879-022-07777-6] [Reference Citation Analysis]
|
| 10 |
Paul Y. Kim, Audrey Y. Kim, Jamie J. Newman, Eleonora Cella, Thomas C. Bishop, Peter J. Huwe, Olga N. Uchakina, Robert J. McKallip, Vance L. Mack, Marnie P. Hill, Ifedayo Victor Ogungbe, Olawale Adeyinka, Samuel Jones, Gregory Ware, Jennifer Carroll, Jarrod F. Sawyer, Kenneth H. Densmore, Michael Foster, Lescia Valmond, John Thomas, Taj Azarian, Krista Queen, Jeremy P. Kamil. A collaborative approach to improve representation in viral genomic surveillance. bioRxiv 2022:2022.10.19.512816. [PMID: 36299431 DOI: 10.1101/2022.10.19.512816] [Reference Citation Analysis]
|
| 11 |
Thompson MG, Yoon SK, Naleway AL, Meece J, Fabrizio TP, Caban-Martinez AJ, Burgess JL, Gaglani M, Olsho LEW, Bateman A, Lundgren J, Grant L, Phillips AL, Groom HC, Stefanski E, Solle NS, Ellingson K, Lutrick K, Dunnigan K, Wesley MG, Guenther K, Hunt A, Mak J, Hegmann KT, Kuntz JL, Bissonnette A, Hollister J, Rose S, Morrill TC, Respet K, Fowlkes AL, Thiese MS, Rivers P, Herring MK, Odean MJ, Yoo YM, Brunner M, Bedrick EJ, Fleary DE, Jones JT, Praggastis J, Romine J, Dickerson M, Khan SM, Lamberte JM, Beitel S, Webby RJ, Tyner HL; HEROES-RECOVER Network. Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers. JAMA 2022;328:1523-33. [PMID: 36255426 DOI: 10.1001/jama.2022.18550] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 12 |
Essaidi-laziosi M, Perez Rodriguez FJ, Alvarez C, Sattonnet-roche P, Torriani G, Bekliz M, Adea K, Lenk M, Preiser W, Suliman T, Muller MA, Drosten C, Kaiser L, Eckerle I. Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species.. [DOI: 10.1101/2022.10.04.510352] [Reference Citation Analysis]
|
| 13 |
Jacobsen H, Katzmarzyk M, Higdon MM, Jiménez VC, Sitaras I, Bar-zeev N, Knoll MD. Post-vaccination neutralization responses to Omicron sub-variants.. [DOI: 10.1101/2022.09.16.22280017] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 14 |
Saade C, Brengel-Pesce K, Gaymard A, Trabaud MA, Destras G, Oriol G, Cheynet V, Debombourg M, Mokdad B, Billaud G, Oblette A, Créhalet H, Giannoli JM, Garrigou C, Generenaz L, Compagnon C, Boibieux A, Lina B, Morfin F, Pozzetto B, Josset L, Touillet-Assant S, Bal A, On Behalf Of Lyon Covid Study Group A. Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections. Emerg Microbes Infect 2022;:1-31. [PMID: 36098494 DOI: 10.1080/22221751.2022.2122578] [Reference Citation Analysis]
|
| 15 |
Follmann D, Janes HE, Buhule OD, Zhou H, Girard B, Marks K, Kotloff K, Desjardins M, Corey L, Neuzil KM, Miller JM, El Sahly HM, Baden LR. Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial. Ann Intern Med 2022;175:1258-65. [PMID: 35785530 DOI: 10.7326/M22-1300] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 16 |
Lu G, Zhang Y, Zhang H, Ai J, He L, Yuan X, Bao S, Chen X, Wang H, Cai J, Wang S, Zhang W, Xu J. Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave. Emerg Microbes Infect 2022;:1-22. [PMID: 35924388 DOI: 10.1080/22221751.2022.2109517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
van Doremalen N, Singh M, Saturday TA, Yinda CK, Perez-perez L, Bohler WF, Weishampel ZA, Lewis M, Schulz JE, Williamson BN, Meade-white K, Gallogly S, Okumura A, Feldmann F, Lovaglio J, Hanley PW, Shaia C, Feldmann H, de Wit E, Munster VJ, Rosenke K. SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta.. [DOI: 10.1101/2022.08.01.502390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Orendáčová M, Kvašňák E. Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications. Front Public Health 2022;10:903568. [DOI: 10.3389/fpubh.2022.903568] [Reference Citation Analysis]
|
| 19 |
Port JR, Yinda CK, Riopelle JC, Weishampel ZA, Saturday TA, Avanzato VA, Schulz JE, Holbrook MG, Barbian K, Perry-gottschalk R, Haddock E, Martens C, Shaia CI, Lambe T, Gilbert SC, van Doremalen N, Munster VJ. Infection- or vaccine mediated immunity reduces SARS-CoV-2 transmission, but increases competitiveness of Omicron in hamsters.. [DOI: 10.1101/2022.07.29.502072] [Reference Citation Analysis]
|
| 20 |
Winnett AV, Akana R, Shelby N, Davich H, Caldera S, Yamada T, Reyna JRB, Romano AE, Carter AM, Kim MK, Thomson M, Tognazzini C, Feaster M, Goh Y, Chew YC, Ismagilov RF. Extreme differences in SARS-CoV-2 Omicron viral loads among specimen types drives poor performance of nasal rapid antigen tests for detecting presumably pre-infectious and infectious individuals, predicting improved performance of combination specimen antigen tests.. [DOI: 10.1101/2022.07.13.22277513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 21 |
Winnett AV, Akana R, Shelby N, Davich H, Caldera S, Yamada T, Reyna JRB, Romano AE, Carter AM, Kim MK, Thomson M, Tognazzini C, Feaster M, Goh Y, Chew YC, Ismagilov RF. SARS-CoV-2 exhibits extreme differences in early viral loads among specimen types suggesting improved detection of pre-infectious and infectious individuals using combination specimen types.. [DOI: 10.1101/2022.07.13.22277113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Rzymski P, Szuster-ciesielska A. The COVID-19 Vaccination Still Matters: Omicron Variant Is a Final Wake-Up Call for the Rich to Help the Poor. Vaccines 2022;10:1070. [DOI: 10.3390/vaccines10071070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 23 |
Park G, Kim S, Maeng J. Development and Evaluation of RT-LAMP Assays to Identify Variants of SARS-CoV-2.. [DOI: 10.1101/2022.06.16.496383] [Reference Citation Analysis]
|
| 24 |
Hoteit R, Yassine HM. Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences. Vaccines (Basel) 2022;10:919. [PMID: 35746526 DOI: 10.3390/vaccines10060919] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 25 |
Tennøe S, Gheorghe M, Stratford R, Clancy T. The T cell epitope landscape of SARS-CoV-2 variants of concern.. [DOI: 10.1101/2022.06.06.491344] [Reference Citation Analysis]
|
| 26 |
Zhou H, Møhlenberg M, Thakor JC, Tuli HS, Wang P, Assaraf YG, Dhama K, Jiang S. Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant. Clin Microbiol Rev. [DOI: 10.1128/cmr.00014-22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 27 |
Marquez C, Kerkhoff AD, Schrom J, Rojas S, Black D, Mitchell A, Wang C, Pilarowski G, Ribeiro S, Jones D, Payan J, Manganelli S, Rojas S, Lemus J, Jain V, Chamie G, Tulier-laiwa V, Petersen M, Derisi J, Havlir DV. COVID-19 symptoms and duration of direct antigen test positivity at a community testing and surveillance site, January 2021-2022.. [DOI: 10.1101/2022.05.19.22274968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
Stokes W, Venner AA, Buss E, Tipples G, Berenger BM. Evaluation of the ID NOW Among Symptomatic Individuals During the Omicron Wave.. [DOI: 10.1101/2022.05.19.22275316] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Garcia-knight M, Anglin K, Tassetto M, Lu S, Zhang A, Goldberg SA, Catching A, Davidson MC, Shak JR, Romero M, Pineda-ramirez J, Sanchez RD, Rugart P, Donohue K, Massachi J, Sans HM, Djomaleu M, Mathur S, Servellita V, Mcilwain D, Gaudiliere B, Chen J, Martinez EO, Tavs JM, Bronstone G, Weiss J, Watson JT, Briggs-hagen M, Abedi GR, Rutherford GW, Deeks SG, Chiu C, Saydah S, Peluso MJ, Midgley CM, Martin JN, Andino R, Kelly JD. Infectious viral shedding of SARS-CoV-2 Delta following vaccination: a longitudinal cohort study.. [DOI: 10.1101/2022.05.15.22275051] [Reference Citation Analysis]
|
| 30 |
Reiter R, Von Blanckenburg P, Mutters R, Thiemer J, Geßner R, Seifart U. Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2. Vaccines 2022;10:788. [DOI: 10.3390/vaccines10050788] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Weil AA, Luiten KG, Casto AM, Bennett JC, O’hanlon J, Han PD, Gamboa L, Mcdermot E, Truong M, Gottlieb GS, Acker Z, Wolf CR, Magedson A, Chow EJ, Lo NK, Pothan LC, Mcdonald D, Wright T, Mccaffrey K, Figgins MD, Englund JA, Boeckh M, Lockwood CM, Nickerson DA, Shendure J, Bedford T, Hughes JP, Starita LM, Chu HY. Mapping the emergence of SARS-CoV-2 Omicron variants on a university campus.. [DOI: 10.1101/2022.04.27.22274375] [Reference Citation Analysis]
|
| 32 |
Follmann D, Janes HE, Buhule OD, Zhou H, Girard B, Marks K, Kotloff K, Desjardins M, Corey L, Neuzil KM, Miller JM, El Sahly HM, Baden LR. Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial.. [DOI: 10.1101/2022.04.18.22271936] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 33 |
Abas AH, Marfuah S, Idroes R, Kusumawaty D, Fatimawali, Park MN, Siyadatpanah A, Alhumaydhi FA, Mahmud S, Tallei TE, Emran TB, Kim B. Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19? Molecules 2022;27:2221. [DOI: 10.3390/molecules27072221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 34 |
Lentini A, Pereira A, Winqvist O, Reinius B. Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 variant transition in the Swedish population reveals higher viral quantity in BA.2 cases.. [DOI: 10.1101/2022.03.26.22272984] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 35 |
Hevesi Z, Gerges DA, Kapps S, Freire R, Schmidt S, Pollak DD, Schmetterer K, Frey T, Lang R, Winnicki W, Schmidt A, Harkany T, Wagner L. Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2. Vaccines 2022;10:516. [DOI: 10.3390/vaccines10040516] [Reference Citation Analysis]
|
| 36 |
Sriraman K, Shaikh A, Vaswani S, Mestry T, Patel G, Sakthivel S, Oswal V, Kadam P, Nilgiriwala K, Shah D, Gomare M, Mistry N. Impact of Delta and Vaccination on SARS-CoV-2 transmission risk: Lessons for Emerging Breakthrough infections.. [DOI: 10.1101/2022.03.02.22271385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Osterman A, Badell I, Basara E, Stern M, Kriesel F, Eletreby M, Öztan GN, Huber M, Autenrieth H, Knabe R, Späth PM, Muenchhoff M, Graf A, Krebs S, Blum H, Durner J, Czibere L, Dächert C, Kaderali L, Baldauf H, Keppler OT. Impaired detection of omicron by SARS-CoV-2 rapid antigen tests. Med Microbiol Immunol. [DOI: 10.1007/s00430-022-00730-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 25.0] [Reference Citation Analysis]
|
| 38 |
Iftner T, Iftner A, Pohle D, Martus P. Evaluation of the specificity and accuracy of SARS-CoV-2 rapid antigen self-tests compared to RT-PCR from 1015 asymptomatic volunteers.. [DOI: 10.1101/2022.02.11.22270873] [Reference Citation Analysis]
|
| 39 |
Sikka R, Wyllie AL, Premsrirut P, Berke EM. COVID Testing in the Workplace: Return to Work Testing in an Occupational Cohort.. [DOI: 10.1101/2022.02.09.22270653] [Reference Citation Analysis]
|
| 40 |
Hevesi Z, Gerges D, Kapps S, Freire R, Schmidt S, Pollak DD, Schmetterer K, Frey T, Lang R, Winnicki W, Schmidt A, Harkany T, Wagner L. Preclinical establishment of a divalent vaccine against SARS-CoV-2.. [DOI: 10.1101/2022.02.10.479919] [Reference Citation Analysis]
|
| 41 |
Sentis C, Billaud G, Bal A, Frobert E, Bouscambert M, Destras G, Josset L, Lina B, Morfin F, Gaymard A, the COVID-Diagnosis HCL Study Group. SARS-CoV-2 Omicron variant, lineage BA.1, is associated with lower viral load in nasopharyngeal samples compared to Delta variant.. [DOI: 10.1101/2022.02.02.22269653] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 42 |
Kislaya I, Peralta-santos A, Borges V, Vieira L, Sousa C, Ferreira B, Pelerito A, Gomes JP, Leite PP, Nunes B. Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variants.. [DOI: 10.1101/2022.01.31.22270200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 43 |
Meyerowitz EA, Richterman A. SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant. Infectious Disease Clinics of North America 2022. [DOI: 10.1016/j.idc.2022.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Lyngse FP, Kirkeby CT, Denwood M, Christiansen LE, Mølbak K, Møller CH, Skov RL, Krause TG, Rasmussen M, Sieber RN, Johannesen TB, Lillebaek T, Fonager J, Fomsgaard A, Møller FT, Stegger M, Overvad M, Spiess K, Mortensen LH. Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households.. [DOI: 10.1101/2022.01.28.22270044] [Cited by in Crossref: 93] [Cited by in F6Publishing: 106] [Article Influence: 93.0] [Reference Citation Analysis]
|
| 45 |
Petros BA, Turcinovic J, Welch NL, White LF, Kolaczyk ED, Bauer MR, Cleary M, Dobbins ST, Doucette-stamm L, Gore M, Nair P, Nguyen TG, Rose S, Taylor BP, Tsang D, Wendlandt E, Hope M, Platt JT, Jacobson KR, Bouton T, Yune S, Auclair JR, Landaverde L, Klapperich CM, Hamer DH, Hanage WP, Macinnis BL, Sabeti PC, Connor JH, Springer M. Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations.. [DOI: 10.1101/2022.01.27.22269787] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 46 |
Focosi D, Maggi F, Casadevall A. Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence. Viruses 2022;14:187. [DOI: 10.3390/v14020187] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 29.0] [Reference Citation Analysis]
|
| 47 |
Kozlov M. How does Omicron spread so fast? A high viral load isn't the answer. Nature 2022. [PMID: 35046586 DOI: 10.1038/d41586-022-00129-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 48 |
Hay JA, Kissler SM, Fauver JR, Mack C, Tai CG, Samant RM, Connolly S, Anderson DJ, Khullar G, Mackay M, Patel M, Kelly S, Manhertz A, Eiter I, Salgado D, Baker T, Howard B, Dudley JT, Mason CE, Nair M, Huang Y, Difiori J, Ho DD, Grubaugh ND, Grad YH. Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: a retrospective cohort study.. [DOI: 10.1101/2022.01.13.22269257] [Cited by in Crossref: 48] [Cited by in F6Publishing: 56] [Article Influence: 48.0] [Reference Citation Analysis]
|
| 49 |
Nguyen VT, Chan LS. COVID-19 Infection: The Virus and Its Origin, the Variants, the Immune Defense, the Multiorgan Autoimmune Reactions, and the Targeted Treatments. AID 2022;12:568-631. [DOI: 10.4236/aid.2022.123042] [Reference Citation Analysis]
|
| 50 |
Hrudey SE, Bischel HN, Charrois J, Chik AHS, Conant B, Delatolla R, Dorner S, Graber TE, Hubert C, Isaac-renton J, Pons W, Safford H, Servos M, Sikora C. Wastewater Surveillance for SARS-CoV-2 RNA in Canada. FACETS 2022;7:1493-1597. [DOI: 10.1139/facets-2022-0148] [Reference Citation Analysis]
|
| 51 |
Tian W, Ren X, Han M, Zhang Y, Gao X, Chen Z, Zhang W. Epidemiological and clinical characteristics of vaccinated COVID-19 patients: A meta-analysis and systematic review. Int J Immunopathol Pharmacol 2022;36:039463202211418. [DOI: 10.1177/03946320221141802] [Reference Citation Analysis]
|
| 52 |
Bekliz M, Perez-rodriguez F, Puhach O, Adea K, Melancia SM, Baggio S, Corvaglia A, Jacquerioz-bausch F, Alvarez C, Essaidi-laziosi M, Escadafal C, Kaiser L, Eckerle I. Sensitivity of SARS-CoV-2 antigen-detecting rapid tests for Omicron variant.. [DOI: 10.1101/2021.12.18.21268018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 53 |
Zhu Y, Chew KY, Wu M, Karawita AC, Mccallum G, Steele LE, Yamamoto A, Labzin LL, Yarlagadda T, Khromykh AA, Wang X, Sng J, Stocks CJ, Xia Y, Kollmann TR, Martino D, Joensuu M, Meunier FA, Balistreri G, Bielefeldt-ohmann H, Bowen AC, Kicic A, Sly PD, Spann KM, Short KR. Pediatric nasal epithelial cells are less permissive to SARS-CoV-2 replication compared to adult cells.. [DOI: 10.1101/2021.03.08.434300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
